Viyash Scientific Limited (BOM:512529)
India · Delayed Price · Currency is INR 252.50
-3.10 (-1.21%)
At close: Aug 17, 2026
Viyash Scientific Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 35,750 | 34,203 | 30,068 | 13,697 | 14,209 | 14,128 | |
Revenue Growth | 123.08% | 13.75% | 119.52% | -3.60% | 0.57% | 3.76% |
Cost of Revenue | 17,044 | 16,507 | 15,543 | 7,853 | 8,581 | 8,149 |
Gross Profit | 18,706 | 17,697 | 14,526 | 5,845 | 5,628 | 5,979 |
Selling, General & Admin | 6,024 | 5,786 | 5,642 | 2,548 | 2,618 | 2,334 |
Other Operating Expenses | 5,472 | 5,348 | 4,956 | 2,448 | 2,605 | 2,547 |
Operating Expenses | 13,915 | 13,490 | 12,989 | 5,612 | 5,781 | 5,400 |
Operating Income | 4,792 | 4,206 | 1,536 | 232.73 | -153.46 | 579.62 |
Interest Expense | -558.4 | -637.6 | -793.35 | -464.23 | -297.19 | -135.09 |
Interest & Investment Income | 92.51 | 92.51 | 68.39 | 6.7 | 12.1 | 4.07 |
Currency Exchange Gain (Loss) | 120.07 | 120.07 | -22.99 | -153.49 | -114.46 | 63.03 |
Other Non Operating Income (Expenses) | 86.75 | 72.05 | 17.19 | 29.97 | -27.11 | 15.52 |
EBT Excluding Unusual Items | 4,533 | 3,853 | 805.71 | -348.32 | -580.12 | 527.15 |
Merger & Restructuring Charges | -429.57 | -442.07 | -42.68 | -228.14 | -421.76 | - |
Impairment of Goodwill | - | - | - | - | -204.09 | - |
Gain (Loss) on Sale of Investments | 10.79 | 10.79 | -51.29 | 0.17 | 0.51 | 3.18 |
Gain (Loss) on Sale of Assets | 36.14 | 36.14 | 116.92 | 55.42 | 20.42 | -0.69 |
Asset Writedown | -0.21 | -0.21 | -2.75 | -1.64 | -1.61 | -0.34 |
Other Unusual Items | -19 | 32.5 | -743.63 | -104.62 | -189.93 | - |
Pretax Income | 4,131 | 3,490 | 131.81 | -546.46 | -1,377 | 529.3 |
Income Tax Expense | 1,460 | 1,244 | -25.86 | -250.33 | -156.81 | 81.66 |
Earnings From Continuing Operations | 2,671 | 2,247 | 157.67 | -296.13 | -1,220 | 447.64 |
Net Income to Company | 2,671 | 2,247 | 157.67 | -296.13 | -1,220 | 447.64 |
Minority Interest in Earnings | -557.46 | -473.66 | 74.52 | -62.56 | 8.18 | -38.09 |
Net Income | 2,113 | 1,773 | 232.19 | -358.69 | -1,212 | 409.55 |
Net Income to Common | 2,113 | 1,773 | 232.19 | -358.69 | -1,212 | 409.55 |
Net Income Growth | 612.13% | 663.53% | - | - | - | -57.09% |
Shares Outstanding (Basic) | 435 | 434 | 431 | 249 | 248 | 247 |
Shares Outstanding (Diluted) | 445 | 442 | 436 | 250 | 248 | 251 |
Shares Change | 72.76% | 1.33% | 74.50% | 0.57% | -0.90% | 1.16% |
EPS (Basic) | 4.86 | 4.09 | 0.54 | -1.44 | -4.88 | 1.66 |
EPS (Diluted) | 4.75 | 4.01 | 0.53 | -1.44 | -4.88 | 1.63 |
EPS Growth | 313.34% | 656.61% | - | - | - | -57.66% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | 1,882 | 2,367 | -2.12 | -693.71 | -18.69 |
Free Cash Flow Per Share | - | 4.26 | 5.43 | -0.01 | -2.79 | -0.07 |
Gross Margin | 52.33% | 51.74% | 48.31% | 42.67% | 39.61% | 42.32% |
Operating Margin | 13.40% | 12.30% | 5.11% | 1.70% | -1.08% | 4.10% |
Profit Margin | 5.91% | 5.18% | 0.77% | -2.62% | -8.53% | 2.90% |
Free Cash Flow Margin | - | 5.50% | 7.87% | -0.01% | -4.88% | -0.13% |
EBITDA | 6,822 | 6,269 | 3,730 | 767.82 | 311.55 | 983.02 |
EBITDA Margin | 19.08% | 18.33% | 12.40% | 5.61% | 2.19% | 6.96% |
D&A For EBITDA | 2,030 | 2,063 | 2,193 | 535.09 | 465.01 | 403.4 |
EBIT | 4,792 | 4,206 | 1,536 | 232.73 | -153.46 | 579.62 |
EBIT Margin | 13.40% | 12.30% | 5.11% | 1.70% | -1.08% | 4.10% |
Effective Tax Rate | 35.34% | 35.63% | - | - | - | 15.43% |
Revenue as Reported | 36,201 | 34,639 | 30,397 | 13,807 | 14,273 | 14,237 |